|

Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions

RECRUITINGSponsored by The University of Texas Health Science Center, Houston
Actively Recruiting
SponsorThe University of Texas Health Science Center, Houston
Started2026-04-07
Est. completion2033-04-01
Eligibility
Age18 Years+
Locations1 site
View on ClinicalTrials.gov →

NCT07737171

Summary

This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Diagnosis of any pancreatic pre-malignant lesion and/or pancreatic malignancy
* Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically

Exclusion Criteria:

* Patients with co-existing malignancies of other organs (or a prior history of such)
* Patients unable to provide informed consent
* Patients unable to complete follow-up

Conditions2

CancerPancreatic Cancer

Locations1 site

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
Amatullah Alibhai, MBA713-500-6658Amatullah.Alibhai@uth.tmc.edu

Find trials near these locations

Cancer trials in HoustonAll trials in Texas

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.